Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Persistent or recurrent symptoms after arthroscopic surgery for femoroacetabular impingement: A review of imaging findings.

Woodward RM, Philippon MJ.

J Med Imaging Radiat Oncol. 2019 Feb;63(1):15-24. doi: 10.1111/1754-9485.12822. Epub 2018 Oct 27. Review.

PMID:
30369089
2.

Teprotumumab for Thyroid-Associated Ophthalmopathy.

Smith TJ, Kahaly GJ, Ezra DG, Fleming JC, Dailey RA, Tang RA, Harris GJ, Antonelli A, Salvi M, Goldberg RA, Gigantelli JW, Couch SM, Shriver EM, Hayek BR, Hink EM, Woodward RM, Gabriel K, Magni G, Douglas RS.

N Engl J Med. 2017 May 4;376(18):1748-1761. doi: 10.1056/NEJMoa1614949.

3.

Quality-adjusted life years in cancer: pros, cons, and alternatives.

Woodward RM, Menzin J, Neumann PJ.

Eur J Cancer Care (Engl). 2013 Jan;22(1):12-9. doi: 10.1111/ecc.12006. Epub 2012 Sep 12.

PMID:
22966947
4.

The future of nursing: community health's network approach.

Adams C, Browning M, Woodward RM.

J Nurs Adm. 2012 Jul-Aug;42(7-8):347-9. doi: 10.1097/NNA.0b013e318261z93bc.

PMID:
22832407
5.

Lost productivity due to premature mortality in developed and emerging countries: an application to smoking cessation.

Menzin J, Marton JP, Menzin JA, Willke RJ, Woodward RM, Federico V.

BMC Med Res Methodol. 2012 Jun 25;12:87. doi: 10.1186/1471-2288-12-87.

6.

W R Gowers 1895: two unpublished post-graduate lectures.

Lees AJ, Woodward RM, Scott AE, Eadie MJ.

Brain. 2012 Oct;135(Pt 10):3165-77. doi: 10.1093/brain/aws029. Epub 2012 Mar 6.

PMID:
22396392
7.

The impact of symptoms and impairments on overall health in US national health data.

Stewart ST, Woodward RM, Rosen AB, Cutler DM.

Med Care. 2008 Sep;46(9):954-62. doi: 10.1097/MLR.0b013e318179199f.

8.

Treatment of specific phobia in older adults.

Pachana NA, Woodward RM, Byrne GJ.

Clin Interv Aging. 2007;2(3):469-76.

9.

The value of medical interventions for lung cancer in the elderly: results from SEER-CMHSF.

Woodward RM, Brown ML, Stewart ST, Cronin KA, Cutler DM.

Cancer. 2007 Dec 1;110(11):2511-8.

10.

Pharmacological characterization of recombinant N-type calcium channel (Cav2.2) mediated calcium mobilization using FLIPR.

Benjamin ER, Pruthi F, Olanrewaju S, Shan S, Hanway D, Liu X, Cerne R, Lavery D, Valenzano KJ, Woodward RM, Ilyin VI.

Biochem Pharmacol. 2006 Sep 14;72(6):770-82. Epub 2006 Jul 17.

PMID:
16844100
11.

Pharmacology of 2-[4-(4-chloro-2-fluorophenoxy)phenyl]-pyrimidine-4-carboxamide: a potent, broad-spectrum state-dependent sodium channel blocker for treating pain states.

Ilyin VI, Pomonis JD, Whiteside GT, Harrison JE, Pearson MS, Mark L, Turchin PI, Gottshall S, Carter RB, Nguyen P, Hogenkamp DJ, Olanrewaju S, Benjamin E, Woodward RM.

J Pharmacol Exp Ther. 2006 Sep;318(3):1083-93. Epub 2006 May 25.

PMID:
16728593
12.

State-dependent compound inhibition of Nav1.2 sodium channels using the FLIPR Vm dye: on-target and off-target effects of diverse pharmacological agents.

Benjamin ER, Pruthi F, Olanrewaju S, Ilyin VI, Crumley G, Kutlina E, Valenzano KJ, Woodward RM.

J Biomol Screen. 2006 Feb;11(1):29-39. Epub 2005 Oct 18.

PMID:
16234337
13.

V102862 (Co 102862): a potent, broad-spectrum state-dependent blocker of mammalian voltage-gated sodium channels.

Ilyin VI, Hodges DD, Whittemore ER, Carter RB, Cai SX, Woodward RM.

Br J Pharmacol. 2005 Mar;144(6):801-12.

14.

3-(4-phenoxyphenyl)pyrazoles: a novel class of sodium channel blockers.

Yang J, Gharagozloo P, Yao J, Ilyin VI, Carter RB, Nguyen P, Robledo S, Woodward RM, Hogenkamp DJ.

J Med Chem. 2004 Mar 11;47(6):1547-52.

PMID:
14998340
15.

Terahertz pulsed imaging and spectroscopy for biomedical and pharmaceutical applications.

Wallace VP, Taday PF, Fitzgerald AJ, Woodward RM, Cluff J, Pye RJ, Arnone DD.

Faraday Discuss. 2004;126:255-63; discussion 303-11.

PMID:
14992411
16.

Terahertz pulsed imaging of skin cancer in the time and frequency domain.

Woodward RM, Wallace VP, Arnone DD, Linfield EH, Pepper M.

J Biol Phys. 2003 Jun;29(2-3):257-9. doi: 10.1023/A:1024409329416.

17.

Synthesis and SAR of novel di- and trisubstituted 1,4-dihydroquinoxaline-2,3-diones related to licostinel (Acea 1021) as NMDA/glycine site antagonists.

Zhou ZL, Kher SM, Cai SX, Whittemore ER, Espitia SA, Hawkinson JE, Tran M, Woodward RM, Weber E, Keana JF.

Bioorg Med Chem. 2003 Apr 17;11(8):1769-80.

PMID:
12659763
18.

Terahertz pulse imaging of ex vivo basal cell carcinoma.

Woodward RM, Wallace VP, Pye RJ, Cole BE, Arnone DD, Linfield EH, Pepper M.

J Invest Dermatol. 2003 Jan;120(1):72-8.

19.

Terahertz pulse imaging in reflection geometry of human skin cancer and skin tissue.

Woodward RM, Cole BE, Wallace VP, Pye RJ, Arnone DD, Linfield EH, Pepper M.

Phys Med Biol. 2002 Nov 7;47(21):3853-63. Review.

PMID:
12452577
20.

Synthesis and SAR of 5-, 6-, 7- and 8-aza analogues of 3-aryl-4-hydroxyquinolin-2(1H)-one as NMDA/glycine site antagonists.

Zhou ZL, Navratil JM, Cai SX, Whittemore ER, Espitia SA, Hawkinson JE, Tran M, Woodward RM, Weber E, Keana JF.

Bioorg Med Chem. 2001 Aug;9(8):2061-71.

PMID:
11504642
21.

Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(heteroarylalkynyl)-4-benzylpiperidines.

Wright JL, Gregory TF, Kesten SR, Boxer PA, Serpa KA, Meltzer LT, Wise LD, Espitia SA, Konkoy CS, Whittemore ER, Woodward RM.

J Med Chem. 2000 Sep 7;43(18):3408-19.

PMID:
10978188
22.

Subtype-selective N-methyl-D-aspartate receptor antagonists: benzimidazalone and hydantoin as phenol replacements.

Schelkun RM, Yuen PW, Serpa K, Meltzer LT, Wise LD, Whittemore ER, Woodward RM.

J Med Chem. 2000 May 4;43(9):1892-7.

PMID:
10794706
23.

Parallel synthesis of a series of subtype-selective NMDA receptor antagonists.

Gregory TF, Wright JL, Wise LD, Meltzer LT, Serpa KA, Konkoy CS, Whittemore ER, Woodward RM.

Bioorg Med Chem Lett. 2000 Mar 20;10(6):527-9.

PMID:
10741546
24.

Synthesis of N-substituted 4-(4-hydroxyphenyl)piperidines, 4-(4-hydroxybenzyl)piperidines, and (+/-)-3-(4-hydroxyphenyl)pyrrolidines: selective antagonists at the 1A/2B NMDA receptor subtype.

Guzikowski AP, Tamiz AP, Acosta-Burruel M, Hong-Bae S, Cai SX, Hawkinson JE, Keana JF, Kesten SR, Shipp CT, Tran M, Whittemore ER, Woodward RM, Wright JL, Zhou ZL.

J Med Chem. 2000 Mar 9;43(5):984-94.

PMID:
10715162
25.

Structure-activity relationship of N-(phenylalkyl)cinnamides as novel NR2B subtype-selective NMDA receptor antagonists.

Tamiz AP, Cai SX, Zhou ZL, Yuen PW, Schelkun RM, Whittemore ER, Weber E, Woodward RM, Keana JF.

J Med Chem. 1999 Aug 26;42(17):3412-20.

PMID:
10464027
26.

Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys.

Blanchet PJ, Konitsiotis S, Whittemore ER, Zhou ZL, Woodward RM, Chase TN.

J Pharmacol Exp Ther. 1999 Sep;290(3):1034-40.

PMID:
10454475
27.

4-Hydroxy-1-[2-(4-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl)piperidine: a novel, potent, and selective NR1/2B NMDA receptor antagonist.

Zhou ZL, Cai SX, Whittemore ER, Konkoy CS, Espitia SA, Tran M, Rock DM, Coughenour LL, Hawkinson JE, Boxer PA, Bigge CF, Wise LD, Weber E, Woodward RM, Keana JF.

J Med Chem. 1999 Jul 29;42(15):2993-3000.

PMID:
10425109
28.

Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(arylalkynyl)-4-benzylpiperidines.

Wright JL, Gregory TF, Bigge CF, Boxer PA, Serpa K, Meltzer LT, Wise LD, Cai SX, Hawkinson JE, Konkoy CS, Whittemore ER, Woodward RM, Zhou ZL.

J Med Chem. 1999 Jul 1;42(13):2469-77.

PMID:
10395488
29.
30.

N-(2-(4-hydroxyphenyl)ethyl)-4-chlorocinnamide: a novel antagonist at the 1A/2B NMDA receptor subtype.

Tamiz AP, Whittemore ER, Schelkun RM, Yuen PW, Woodward RM, Cai SX, Weber E, Keana JF.

Bioorg Med Chem Lett. 1998 Jan 20;8(2):199-200.

PMID:
9871654
31.

Substituted 3beta-phenylethynyl derivatives of 3alpha-hydroxy-5alpha-pregnan-20-one: remarkably potent neuroactive steroid modulators of gamma-aminobutyric acidA receptors.

Hawkinson JE, Acosta-Burruel M, Yang KC, Hogenkamp DJ, Chen JS, Lan NC, Drewe JA, Whittemore ER, Woodward RM, Carter RB, Upasani RB.

J Pharmacol Exp Ther. 1998 Oct;287(1):198-207.

PMID:
9765338
32.

Structure-activity relationships for a series of bis(phenylalkyl)amines: potent subtype-selective inhibitors of N-methyl-D-aspartate receptors.

Tamiz AP, Whittemore ER, Zhou ZL, Huang JC, Drewe JA, Chen JC, Cai SX, Weber E, Woodward RM, Keana JF.

J Med Chem. 1998 Aug 27;41(18):3499-506.

PMID:
9719603
33.

Synthesis of 7,8-(methylenedioxy)-1-phenyl-3,5-dihydro-4H-2, 3-benzodiazepin-4-ones as novel and potent noncompetitive AMPA receptor antagonists.

Wang Y, Konkoy CS, Ilyin VI, Vanover KE, Carter RB, Weber E, Keana JF, Woodward RM, Cai SX.

J Med Chem. 1998 Jul 2;41(14):2621-5.

PMID:
9651166
34.

Subtype-selective antagonism of NMDA receptors by nylidrin.

Whittemore ER, Ilyin VI, Konkoy CS, Woodward RM.

Eur J Pharmacol. 1997 Oct 22;337(2-3):197-208.

PMID:
9430414
35.

5-(N-oxyaza)-7-substituted-1,4-dihydroquinoxaline-2,3-diones: novel, systemically active and broad spectrum antagonists for NMDA/glycine, AMPA, and kainate receptors.

Cai SX, Huang JC, Espitia SA, Tran M, Ilyin VI, Hawkinson JE, Woodward RM, Weber E, Keana JF.

J Med Chem. 1997 Oct 24;40(22):3679-86.

PMID:
9357535
37.

Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition.

Whittemore ER, Ilyin VI, Woodward RM.

J Pharmacol Exp Ther. 1997 Jul;282(1):326-38.

PMID:
9223571
38.

Partial agonism by 3alpha,21-dihydroxy-5beta-pregnan-20-one at the gamma-aminobutyric acidA receptor neurosteroid site.

Xue BG, Whittemore ER, Park CH, Woodward RM, Lan NC, Gee KW.

J Pharmacol Exp Ther. 1997 Jun;281(3):1095-101.

PMID:
9190841
39.

Antinociceptive effects of NMDA and non-NMDA receptor antagonists in the tail flick test in mice.

Lutfy K, Cai SX, Woodward RM, Weber E.

Pain. 1997 Mar;70(1):31-40.

PMID:
9106807
40.

Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.

Cai SX, Kher SM, Zhou ZL, Ilyin V, Espitia SA, Tran M, Hawkinson JE, Woodward RM, Weber E, Keana JF.

J Med Chem. 1997 Feb 28;40(5):730-8.

PMID:
9057859
41.

3 alpha-Hydroxy-3 beta-(phenylethynyl)-5 beta-pregnan-20-ones: synthesis and pharmacological activity of neuroactive steroids with high affinity for GABAA receptors.

Upasani RB, Yang KC, Acosta-Burruel M, Konkoy CS, McLellan JA, Woodward RM, Lan NC, Carter RB, Hawkinson JE.

J Med Chem. 1997 Jan 3;40(1):73-84.

PMID:
9016330
42.

Synthesis and in vitro activity of 3 beta-substituted-3 alpha-hydroxypregnan-20-ones: allosteric modulators of the GABAA receptor.

Hogenkamp DJ, Tahir SH, Hawkinson JE, Upasani RB, Alauddin M, Kimbrough CL, Acosta-Burruel M, Whittemore ER, Woodward RM, Lan NC, Gee KW, Bolger MB.

J Med Chem. 1997 Jan 3;40(1):61-72.

PMID:
9016329
43.

Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.

Ilyin VI, Whittemore ER, Guastella J, Weber E, Woodward RM.

Mol Pharmacol. 1996 Dec;50(6):1541-50.

PMID:
8967976
44.

Structure-activity relationships of 4-hydroxy-3-nitroquinolin-2(1H)-ones as novel antagonists at the glycine site of N-methyl-D-aspartate receptors.

Cai SX, Zhou ZL, Huang JC, Whittemore ER, Egbuwoku ZO, Hawkinson JE, Woodward RM, Weber E, Keana JF.

J Med Chem. 1996 Nov 8;39(23):4682-6.

PMID:
8917657
45.

Analogs of 3-hydroxy-1H-1-benzazepine-2,5-dione: structure-activity relationship at N-methyl-D-aspartate receptor glycine sites.

Guzikowski AP, Cai SX, Espitia SA, Hawkinson JE, Huettner JE, Nogales DF, Tran M, Woodward RM, Weber E, Keana JF.

J Med Chem. 1996 Nov 8;39(23):4643-53.

PMID:
8917653
46.

Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes.

Whittemore ER, Yang W, Drewe JA, Woodward RM.

Mol Pharmacol. 1996 Nov;50(5):1364-75.

PMID:
8913369
47.

Design and in vitro pharmacology of a selective gamma-aminobutyric acidC receptor antagonist.

Ragozzino D, Woodward RM, Murata Y, Eusebi F, Overman LE, Miledi R.

Mol Pharmacol. 1996 Oct;50(4):1024-30. Erratum in: Mol Pharmacol. 2013 Jun;83(6):1276.

PMID:
8863850
48.

Pharmacology of ACEA-1416: a potent systemically active NMDA receptor glycine site antagonist.

Ilyin VI, Whittemore ER, Tran M, Shen KZ, Cai SX, Kher SM, Keana JF, Weber E, Woodward RM.

Eur J Pharmacol. 1996 Aug 29;310(2-3):107-14.

PMID:
8884205
49.

Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test.

Lutfy K, Shen KZ, Woodward RM, Weber E.

Brain Res. 1996 Aug 26;731(1-2):171-81.

PMID:
8883867
50.

Synthesis and structure-activity relationships of 1,2,3,4-tetrahydroquinoline-2,3,4-trione 3-oximes: novel and highly potent antagonists for NMDA receptor glycine site.

Cai SX, Zhou ZL, Huang JC, Whittemore ER, Egbuwoku ZO, Lü Y, Hawkinson JE, Woodward RM, Weber E, Keana JF.

J Med Chem. 1996 Aug 16;39(17):3248-55.

PMID:
8765507

Supplemental Content

Loading ...
Support Center